PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
63.23
-0.47 (-0.74%)
Oct 7, 2026, 4:00 PM EDT - Market closed
PTC Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $122 | Buy | Maintains | $122 | +92.95% | Oct 7, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $85 | Hold | Maintains | $85 | +34.43% | Oct 7, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $130 → $137 | Buy | Reiterates | $130 → $137 | +116.67% | Sep 22, 2026 |
| Leerink Partners | Leerink Partners | Buy Initiates $70 → $98 | Buy | Initiates | $70 → $98 | +54.99% | Sep 14, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $109 | Buy | Maintains | $109 | +72.39% | Sep 2, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $90 | Buy | Maintains | $90 | +42.34% | Aug 31, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $96 | Buy | Maintains | $96 | +51.83% | Aug 13, 2026 |
| Goldman Sachs | Goldman Sachs | Sell Maintains $70 | Sell | Maintains | $70 | +10.71% | Jul 31, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.